Effectiveness of substituting cyclosporin A with tacrolimus in reducing gingival overgrowth in renal transplant patients

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 14, Issue 9, 2009, Pages

  Párraga Linares, Laura ^a   Almendros Marqués, Nieves ^a   Berini Aytés, Leonardo ^a,b,c   Gay Escoda, Cosme ^a,c,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Barcelona University Dental School ^*

^c UB IDIBELL Research Group   (United States)

^d CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Cyclosporin A kidney transplant; Gingival overgrowth; Immunosuppressants; Tacrolimus

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUID RETENTION; GINGIVA OVERGROWTH; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LYMPHOMA; MALE; MOUTH HYGIENE; NEPHROTOXICITY; NEUROTOXICITY; PERIODONTAL DISEASE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN TUMOR; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CYCLOSPORINE; FEMALE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 69949099063     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kantarci A, Cebeci I, Tuncer O, Carin M, Firatli E. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol. 1999;70:587-593 (Pubitemid 29284151)
2. Ciavarella D, Guiglia R, Campisi G, Di Cosola M, Di Liberto C, Sabatucci A, et al. Update on gingival overgrowth by cyclosporine A in renal transplants. Med Oral Patol Oral Cir Bucal. 2007;12:E19-25. (Pubitemid 46143081)
3. De la Rosa-García E, Mondragón-Padilla A, Irigoyen-Camacho ME, Bustamante-Ramírez MA. Oral lesions in a group of kidney transplant patients. Med Oral Patol Oral Cir Bucal. 2005;10:196-204. (Pubitemid 40675880)
4. Spolidorio LC, Spolidorio DM, Massucato EM, Neppelenbroek KH, Campanha NH, Sanches MH. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. Oral Dis. 2006;12:309-314 (Pubitemid 43736421)
5. Díaz-Ortiz ML, Micó-Llorens JM, Gargallo-Albiol J, Baliellas- Comellas C, Berini-Aytés L, Gay-Escoda C. Dental health in liver transplant patients. Med Oral Patol Oral Cir Bucal. 2005;10:72-6; 66-72. (Pubitemid 40516504)
6. Thomason JM, Kelly PJ, Seymour RA. The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol. 1996;23:367-371 (Pubitemid 126731963)
7. Daley TD, Wysocki GP. Cyclosporine therapy. Its significance to the periodontist. J Periodontol. 1984;55:708-712
8. Bartold PM. Cyclosporine and gingival overgrowth. J Oral Pathol. 1987;16:463-468
9. Khoury N, Kriaa F, Hiesse C, Von Ey F, Durbach A, Ammor M, et al. Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression. Transplant Proc. 2000;32:2763-2764 (Pubitemid 32008228)
10. Jacobson P, Uberti J, Davis W, Ratanatharathorn V. Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation. Bone Marrow Transplant. 1998;22:217-225 (Pubitemid 28382985)
11. Prabhu A, Mehta DS. A morphologic comparison of gingival changes influenced by cyclosporin and tacrolimus in rats: an experimental study. J Periodontol. 2006;77:265-270 (Pubitemid 44725080)
12. James JA, Boomer S, Maxwell AP, Hull PS, Short CD, Campbell BA, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol. 2000;27:144-148
13. Afonso M, Bello Vde O, Shibli JA, Sposto MR. Cyclosporin A-induced gingival overgrowth in renal transplant patients. J Periodontol. 2003;74:51-56
14. James JA, Marley JJ, Jamal S, Campbell BA, Short CD, Johnson RW, et al. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol. 2000;27:109-115
15. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol. 1986;62:417-421 (Pubitemid 17197257)
16. Daly CG. Resolution of cyclosporin A (CsA)-induced gingival enlargement following reduction in CsA dosage. J Clin Periodontol. 1992;19:143-145
17. De Oliveira Costa F, Diniz Ferreira S, De Miranda Cota LO, Da Costa JE, Aguiar MA. Prevalence, severity, and risk variables associated with gingival overgrowth in renal transplant subjects treated under tacrolimus or cyclosporin regimens. J Periodontol. 2006;77:969-975
18. Ellis JS, Seymour RA, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol. 2004;31:126-131
19. Sekiguchi RT, Paixão CG, Saraiva L, Romito GA, Pannuti CM, Lotufo RF. Incidence of tacrolimus-induced gingival overgrowth in the absence of calcium channel blockers: a short-term study. J Clin Periodontol. 2007;34:545-550
20. Hernández G, Arriba L, Frías MC, De la Macorra JC, De Vicente JC, Jiménez C, et al. Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series. J Periodontol. 2003;74:1816-1823 (Pubitemid 38181226)